Colgin L M, Wilkinson C, Englezou A, Kilian A, Robinson M O, Reddel R R
Children's Medical Research Institute, Westmead, New South Wales, Australia.
Neoplasia. 2000 Sep-Oct;2(5):426-32. doi: 10.1038/sj.neo.7900112.
The telomerase catalytic subunit (hTERT) is an essential component of the holoenzyme complex that adds telomeric repeats to the ends of human chromosomes. Maintenance of telomeres by telomerase or another mechanism is required for cell immortalization, and loss of telomeric DNA has been proposed as a trigger for cellular senescence. Available evidence suggests that regulation of telomerase activity primarily depends on transcriptional control of hTERT. However, several human tissues as well as some normal cell strains have been shown to express low levels of hTERT mRNA even though they lack telomerase activity. We have previously identified six splice variants of hTERT, including a "deletion" variant (hTERTalpha) that is missing conserved residues from the catalytic core of the protein. Several of the deletion variants have been detected in normal and developing human tissues. We now show that hTERTalpha inhibits endogenous telomerase activity, which results in telomere shortening and chromosome end-to-end fusions. Telomerase inhibition induced a senescence-like state in HT1080 cells and apoptosis in a jejunal fibroblast cell line. These results suggest a possible role for hTERT splice variants in the regulation of telomerase activity.
端粒酶催化亚基(hTERT)是全酶复合物的重要组成部分,该复合物可在人类染色体末端添加端粒重复序列。细胞永生化需要通过端粒酶或其他机制维持端粒,并且端粒DNA的丢失被认为是细胞衰老的触发因素。现有证据表明,端粒酶活性的调节主要取决于hTERT的转录控制。然而,已发现几种人类组织以及一些正常细胞系即使缺乏端粒酶活性也会表达低水平的hTERT mRNA。我们之前已鉴定出hTERT的六种剪接变体,包括一种“缺失”变体(hTERTα),该变体缺少蛋白质催化核心的保守残基。在正常和发育中的人类组织中已检测到几种缺失变体。我们现在表明,hTERTα抑制内源性端粒酶活性,导致端粒缩短和染色体端对端融合。端粒酶抑制在HT1080细胞中诱导出类似衰老的状态,并在空肠成纤维细胞系中诱导细胞凋亡。这些结果表明hTERT剪接变体在端粒酶活性调节中可能发挥作用。